TLR3 and colitis: Mice pre-treated with the TLR3 agonist poly(I:C) and the TLR7 agonist, imiquimod, were protected from DSS-induced colitis, whereas mice deficient in both TLR3 and TLR7 were more susceptible to DSS-induced colitis.